Tango Therapeutics, Inc. (TNGX)
20.56
-4.31
(-17.33%)
USD |
NASDAQ |
May 15, 16:00
20.51
-0.05
(-0.24%)
Pre-Market: 20:00
Tango Therapeutics Shareholders Equity (Quarterly) : 391.51M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.500B |
| Kodiak Sciences, Inc. | 112.10M |
| Recursion Pharmaceuticals, Inc. | 1.025B |
| Hims & Hers Health, Inc. | 446.17M |
| Erasca, Inc. | 393.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 435.79M |
| Total Liabilities (Quarterly) | 44.29M |
| Debt to Equity Ratio | 0.0837 |
| Current Ratio | 27.38 |
| Net Debt Paydown Yield | 0.02% |